Western Standard LLC’s Trillium Therapeutics Inc. TRIL Stock Holding History

Western Standard LLC’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-265,355	Closed	-$4.66M	–	44
2021 Q3	$4.66M	Buy	+265,355	New	+$3.1M	2.65%	17

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Western Standard LLC's TRIL Position: Q4 2021 in Review

Western Standard LLC sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 265,355 shares — an estimated $4.66M sold.

Western Standard LLC first reported a position in TRIL in Q3 2021 and held it in 1 quarter. The position peaked at $4.66M in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

Western Standard LLC reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
Western Standard LLC sold 265,355 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $4.66M.
Western Standard LLC first reported a position in Trillium Therapeutics Inc. in Q3 2021 and held it in 1 quarter.
Western Standard LLC's Trillium Therapeutics Inc. position peaked at $4.66M in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on Western Standard LLC's 13F filing for Q4 2021, filed 14 Feb 2022.